Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / GOSS - Gossamer Bio EPS misses by $0.09


GOSS - Gossamer Bio EPS misses by $0.09

Gossamer Bio (GOSS): Q4 GAAP EPS of -$0.88 misses by $0.09.Cash, equivalents and marketable securities totaled $512.6M.Seralutinib (GB002) and GB004 continue to progress through ongoing Phase 2 TORREY and SHIFT-UC clinical trials for Pulmonary Arterial Hypertension and Ulcerative Colitis, respectively. Topline results for both ongoing Phase 2 trials expected in the first half of 2022, subject to developments in the ongoing COVID-19 pandemic.Press Release

For further details see:

Gossamer Bio EPS misses by $0.09
Stock Information

Company Name: Gossamer Bio Inc.
Stock Symbol: GOSS
Market: NYSE
Website: gossamerbio.com

Menu

GOSS GOSS Quote GOSS Short GOSS News GOSS Articles GOSS Message Board
Get GOSS Alerts

News, Short Squeeze, Breakout and More Instantly...